Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study

OBJECTIVES: Tocilizumab has been proposed as a candidate therapy for patients with severe coronavirus disease 2019 (COVID-19), especially among those with higher systemic inflammation. We investigated the association between receipt of tocilizumab and mortality in a large cohort of hospitalized pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Sanz, Javier, Muriel, Alfonso, Ron, Raquel, Herrera, Sabina, Pérez-Molina, José A., Moreno, Santiago, Serrano-Villar, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510451/
https://www.ncbi.nlm.nih.gov/pubmed/32979572
http://dx.doi.org/10.1016/j.cmi.2020.09.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510451/
https://www.ncbi.nlm.nih.gov/pubmed/32979572
http://dx.doi.org/10.1016/j.cmi.2020.09.021

Ejemplares similares